STAAR Surgical (NASDAQ:STAA) Major Shareholder Broadwood Partners, L.P. Buys 8,221 Shares

STAAR Surgical (NASDAQ:STAA) major shareholder Broadwood Partners, L.P. purchased 8,221 shares of the company’s stock in a transaction dated Thursday, January 16th. The stock was purchased at an average price of $21.50 per share, with a total value of $176,751.50. Following the completion of the purchase, the insider now directly owns 10,878,007 shares in the company, valued at $233,877,150.50. The trade was a 0.08 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Broadwood Partners, L.P. also recently made the following trade(s):

• On Tuesday, January 14th, Broadwood Partners, L.P. bought 21,155 shares of STAAR Surgical stock. The stock was purchased at an average price of $21.46 per share, with a total value of $453,986.30.
• On Wednesday, December 18th, Broadwood Partners, L.P. purchased 23,000 shares of STAAR Surgical stock. The shares were purchased at an average price of $24.33 per share, for a total transaction of $559,590.00.
• On Monday, December 16th, Broadwood Partners, L.P. bought 53,500 shares of STAAR Surgical stock. The shares were acquired at an average price of $24.24 per share, for a total transaction of $1,296,840.00.

STAAR Surgical Trading Up 2.0 %

Shares of STAAR Surgical stock opened at $22.29 on Friday. The business has a 50-day moving average price of $25.38 and a two-hundred day moving average price of $31.83. STAAR Surgical has a 1-year low of $21.13 and a 1-year high of $52.68. The company has a market cap of $1.10 billion, a P/E ratio of 50.66 and a beta of 0.63.

Institutional Investors Weigh In On STAAR Surgical

Several large investors have recently added to or reduced their stakes in the business. Granite Investment Partners LLC acquired a new position in STAAR Surgical in the second quarter valued at approximately $17,237,000. Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of STAAR Surgical by 50.1% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 592,621 shares of the medical instruments supplier’s stock valued at $28,215,000 after acquiring an additional 197,717 shares during the period. JPMorgan Chase & Co. boosted its stake in STAAR Surgical by 411.7% during the third quarter. JPMorgan Chase & Co. now owns 214,750 shares of the medical instruments supplier’s stock worth $7,978,000 after acquiring an additional 172,779 shares in the last quarter. American Capital Management Inc. grew its holdings in STAAR Surgical by 42.9% in the third quarter. American Capital Management Inc. now owns 512,813 shares of the medical instruments supplier’s stock worth $19,051,000 after purchasing an additional 154,037 shares during the period. Finally, Dimensional Fund Advisors LP grew its holdings in STAAR Surgical by 25.9% in the second quarter. Dimensional Fund Advisors LP now owns 459,655 shares of the medical instruments supplier’s stock worth $21,884,000 after purchasing an additional 94,422 shares during the period. Institutional investors and hedge funds own 96.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on STAA. Canaccord Genuity Group dropped their price target on shares of STAAR Surgical from $31.00 to $28.00 and set a “hold” rating for the company in a research note on Monday, December 9th. Needham & Company LLC reaffirmed a “hold” rating on shares of STAAR Surgical in a research report on Tuesday, January 7th. Finally, Stephens raised STAAR Surgical to a “hold” rating in a report on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $42.83.

STAAR Surgical Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.